Details of the Drug
General Information of Drug (ID: DMPRBO1)
| Drug Name |
7-Allyl-1,3-dimethyl-3,7-dihydro-purine-2,6-dione
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
7-Allyltheophylline; Theophylline, 7-allyl-; 61444-26-6; UNII-NC789Z71XR; BRN 0226015; CHEMBL24289; NC789Z71XR; 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-7-(2-propenyl)-; 7-Allyl-1,3-dimethyl-3,7-dihydro-purine-2,6-dione; 7-allyl-1,3-dimethylxanthine; 7-Allyl-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione; 1,3-dimethyl-7-(prop-2-en-1-yl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione; NSC521015; AC1L2QUV; ChemDiv2_003783; 1,3-dimethyl-7-prop-2-enylpurine-2,6-dione; Cambridge id 6249500; AC1Q3ZA3; SCHEMBL316279
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 220.23 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 0.3 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


